Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
ClinicalTrials.gov Identifier:
NCT01766778
First received: January 9, 2013
Last updated: February 23, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)